Healthcare Realty Trust Incorporated (NYSE:HR – Get Free Report) COO Robert Hull sold 21,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $19.11, for a total value of $401,310.00. Following the transaction, the chief operating officer directly owned 276,338 shares in the company, valued at $5,280,819.18. The trade was a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Healthcare Realty Trust Trading Up 0.1%
HR opened at $18.89 on Friday. The stock’s fifty day simple moving average is $20.08 and its 200 day simple moving average is $19.40. Healthcare Realty Trust Incorporated has a 1-year low of $16.31 and a 1-year high of $22.04. The stock has a market cap of $6.48 billion, a PE ratio of -72.67 and a beta of 0.95.
Healthcare Realty Trust (NYSE:HR – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The real estate investment trust reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.53). Healthcare Realty Trust had a negative return on equity of 1.91% and a negative net margin of 7.59%.The company had revenue of $278.58 million for the quarter, compared to the consensus estimate of $271.60 million. During the same period last year, the firm earned $0.41 earnings per share. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. Healthcare Realty Trust has set its FY 2026 guidance at 1.620-1.660 EPS. Equities analysts forecast that Healthcare Realty Trust Incorporated will post 1.65 earnings per share for the current year.
Healthcare Realty Trust Dividend Announcement
Analyst Upgrades and Downgrades
HR has been the subject of several research reports. Raymond James Financial began coverage on shares of Healthcare Realty Trust in a research report on Tuesday, June 16th. They set an “outperform” rating and a $24.00 price objective for the company. JPMorgan Chase & Co. upped their target price on Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Weiss Ratings upgraded Healthcare Realty Trust from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Royal Bank Of Canada lifted their price target on Healthcare Realty Trust from $21.00 to $22.00 and gave the stock a “sector perform” rating in a report on Friday, August 7th. Finally, BTIG Research reissued a “buy” rating and set a $22.00 price target on shares of Healthcare Realty Trust in a report on Friday, June 12th. Four equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $21.89.
Check Out Our Latest Stock Analysis on Healthcare Realty Trust
Institutional Trading of Healthcare Realty Trust
Several hedge funds and other institutional investors have recently bought and sold shares of HR. Dynamic Technology Lab Private Ltd acquired a new position in shares of Healthcare Realty Trust during the 1st quarter worth approximately $205,000. Empowered Funds LLC acquired a new stake in shares of Healthcare Realty Trust in the first quarter valued at approximately $202,000. Invesco Ltd. boosted its stake in shares of Healthcare Realty Trust by 48.9% in the second quarter. Invesco Ltd. now owns 2,307,109 shares of the real estate investment trust’s stock valued at $36,591,000 after buying an additional 757,542 shares during the period. First Trust Advisors LP grew its position in Healthcare Realty Trust by 314.1% during the second quarter. First Trust Advisors LP now owns 223,125 shares of the real estate investment trust’s stock worth $3,539,000 after buying an additional 169,248 shares in the last quarter. Finally, Amundi increased its stake in Healthcare Realty Trust by 154.0% during the 2nd quarter. Amundi now owns 519,816 shares of the real estate investment trust’s stock worth $8,343,000 after acquiring an additional 315,179 shares during the period.
Healthcare Realty Trust Company Profile
Healthcare Realty Trust Incorporated is a real estate investment trust focused on owning, developing, acquiring, leasing and managing outpatient healthcare properties. Its portfolio primarily includes medical office buildings and other facilities that support outpatient care, such as ambulatory care centers and healthcare campuses.
The company serves healthcare providers across the United States, with properties generally located near hospitals and in major and growing markets. Its customers include health systems, physician groups and other healthcare providers.
See Also
- Five stocks we like better than Healthcare Realty Trust
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
